Fixing the genes to cure inherited blindness
Guardian - 04-Mar-2020Crispr gene editing is a great but a dangerous tool
Join the club for FREE to access the whole archive and other member benefits.
Assistant Professor of Ophthalmology at Harvard Medical School
Dr. Jason Comander is a member of the Mass Eye and Ear Inherited Retinal Disorders Service and Retina Service, where he specializes in diagnosing and treating inherited retinal diseases. He is also a member of the Ocular Genomics Institute, the Berman-Gund Laboratory for Retinal Degenerations, and the Howe Laboratory.
As a clinician-scientist, Dr. Comander's research primarily focuses on the genetics and treatment of inherited retinal diseases. He has studied the genetic basis of distinct forms of retinitis pigmentosa, investigated methods to assay the functional significance of human mutations, and tested techniques for retinal gene therapy in primates. He also is an investigator and surgeon for a number of ongoing clinical trials for patients with inherited retinal disorders.
Visit website: http://comander.com/
See also: Harvard Medical School - Graduate medical school of Harvard University
Details last updated 07-Mar-2020
Crispr gene editing is a great but a dangerous tool